Inspiring young scientists

We're exciting young minds with the real world possibilities of science.

Innovation

Putting everyday shoppers at the heart of innovation

Innovation

COPD: Our relentless pursuit for better breathing

Today is World COPD Day. A day aimed at raising awareness of COPD, a chronic disease of the lungs, which affects around 329 million people worldwide.

Access to healthcare

Taking action to stop pneumonia

Pneumonia is a preventable and treatable disease. Yet it is still one of the world’s leading causes of death in children under five years old: in 2015 almost one million children under five lost their lives due to this deadly disease. 12 November 2016 is World Pneumonia Day. On this day we will join others in raising awareness of the disease and taking action to tackle it.

Innovation

Getting on target in autoimmune diseases

Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs. However in some people, these cells may malfunction (or ‘go awry’) and start to attack healthy tissue leading to autoimmune diseases which can have a major impact on patients daily lives. Some common autoimmune diseases include type-1 diabetes, inflammatory bowel disease, rheumatoid arthritis and lupus.

Innovation

How smart is your inhaler?

We think it’s about to get a whole lot smarter. In the dawning of the digital age, we’re exploring how the growing ‘internet of things’ can help us to bring digital, and all the opportunities that come with it, into our respiratory research, medicines and devices.

Our people

Pharma, Phnom Penh and Parenthood: Deborah’s story

Patients & consumers

Maternal immunization: Helping protect mums and babies

Patients & consumers

Can social media help us hear patients?

Whether it’s rating their healthcare provider or discussing their medicines.

Our people

Tackling tomorrow’s health challenges today

Our Chief Scientist, Rino Rappuoli, explains how science is helping create the vaccines of tomorrow

Patients & consumers

Don’t forget the pharmacists

Dr. Sharmila Ramachandran and Dr. Aruni Mulgirigama talk about the essential role of pharmacists in asthma care

How we do business

Switching on to consumer choice: Medicines for everyday health

How our consumer strategy is improving quality of life and access to established medicines through innovation

Access to healthcare

Rabies – Educate, Vaccinate, Eliminate.

Our people

Partnership for Prevention

How we do business

Collaboration: unlocking a new approach to clinical trials

Collaboration: unlocking a new approach to clinical trials

Innovation

Scientists or detectives? Seeking new clues in COPD

Scientists or detectives? Seeking new clues in COPD

How we do business

Helping to change the world

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

Access to healthcare

A new response to humanitarian crises

Humanitarian crises are becoming more frequent, more widespread and more complex. It’s clear that a new approach is needed.

Our people

A partnership that is all about the chemistry

Innovation

Can an iPhone transform the way we monitor and improve patient health?

Access to healthcare

The app that could save lives

How our partnership with Save the Children is boosting healthcare innovation that supports vulnerable children.

Our people

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Our people

Engineering a successful career

Celebrating UK National Women in Engineering Day, Suzanne talks about the importance of networks, facing adversity and embracing your weaknesses.

Innovation

Inhaler innovation: more than a simple piece of plastic

Most of us will know someone who suffers from asthma and uses an inhaler regularly to control their condition.

Innovation

From microscope to telescope and beyond – exploring with NASA's CASIS

Access to healthcare

Meet Baby Mckline: a special delivery from our Save the Children partnership

Access to healthcare

Pro Mujer: supporting healthier lives in Latin America

Since 2009, we have been working with Pro Mujer, helping women like Rosa lift themselves and their families out of poverty, and giving them access to high-quality, low-cost healthcare, often for the first time.

Our people

From academia to industry: a new challenge

Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.

Our people

Andy Dundon: the design behind the device

Andy Dundon leads our Research and Development (R&D) Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices, including through the use of digital technologies.

Patients & consumers

Groundswell: 2016 GSK IMPACT Awards Overall Winner

Groundswell is one of ten charities to win a 2016 GSK IMPACT Award, run in partnership with the King’s Fund.

Patients & consumers

Age UK South Lakeland: 2016 GSK IMPACT Award winner

Patients & consumers

Promoting a More Inclusive Society (PAMIS): 2016 GSK IMPACT Award winner

Patients & consumers

An 'everyday' world first in clinical trials

The way we design and carry out clinical trials is being turned on its head by the advent of the Salford Lung Study (SLS).

Patients & consumers

Body & Soul: 2016 GSK IMPACT Award winner

Body & Soul is one of ten charities to win a 2016 GSK IMPACT Award, run in partnership with The King’s Fund.

Access to healthcare

The 30-year quest for world's first malaria vaccine

Dr Joe Cohen recalls his experiences of being part of the team to develop what could be the world’s first vaccine against malaria

Innovation

Turning the tide on antibiotic resistance| New antibiotics

Turning the tide on antibiotic resistance.

Patients & consumers

Does lupus really know no boundaries?

Our people

Clinical Trials: Q&A with Murray Stewart

Access to healthcare

Giving mothers and babies a healthier start

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries

Patients & consumers

Living with severe asthma

What does today look like for you? Perhaps you’ll get up, head to work, meet friends for dinner – and then home to bed, so you are ready and refreshed to do it all again tomorrow.

Our people

Respiratory disease: why we want to make a difference

Today too many people suffer unnecessarily because of the poor management of their asthma and COPD.

Our people

Safety first: Employee wellbeing rides on it

Rajendra is a medical representative in India. He commutes 30 kilometres everyday by motorcycle - and that doesn't even include the time spent on the road during the day.

How we do business

The power of partnerships: transforming vaccine coverage in Mozambique

Innovation

Vaccine manufacture: it’s complicated

Patients & consumers

A story by numbers - Meningococcal Disease

Meningococcal disease, commonly called meningitis, is a sudden, potentially life-threatening illness.

Patients & consumers

What parents know about meningococcal disease

We asked parents of young children in five countries what they know about meningococcal disease. Their responses will help focus our campaign to educate people about the disease and how to help protect against it.

Our people

Beyond manufacturing in Chile and Madagascar

In 2015, GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work.

Our people

Why I #fightmalaria: Laura's story

Laura is a scientist and a mum. Here she describes what motivates her to fight against malaria.

Access to healthcare

The value of vaccination

Patients & consumers

Creating a win for disease prevention

Innovation

Playing the innovation game

Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks.

Patients & consumers

Win for Meningitis

Meningococcal disease, commonly called meningitis, is a sudden, potentially life-threatening illness. Through our Win for Meningitis campaign, we’re helping to raise awareness of this damaging disease.

Patients & consumers

Living with Lupus – a patient perspective

Beth, a Lupus patient, provides insights into the day-to-day challenges of living with this chronic condition.

How we do business

Does the relationship between the pharmaceutical industry and healthcare professionals need to change?

We have made a number of changes to how we interact with healthcare professionals (HCPs), including how we incentivise our pharmaceutical sales representatives, how we support medical education and stopping payments to external HCPs to speak on our behalf about our prescription medicines.

Innovation

Take a deep breath – your lung microbiome will appreciate it

Patients & consumers

Helping to further science and research – Howard’s perspective

Innovation

TB or not TB

As recently as 30 years ago, tuberculosis (TB) was believed to be under control.

Innovation

GSK’s Chief Immunology Officer discusses unlocking the secrets of the immune system to tackle disease

As science evolves we are learning that the immune system does so much more than protect us from an outside attack.

Innovation

Bioelectronics at SXSW 2016

SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology.

How we do business

Helping communities | GSK Impact Awards

The King’s Fund is a charity focused on improving healthcare in the UK. In partnership with GSK, The King’s Fund manages the annual GSK IMPACT Awards.

Patients & consumers

Healthcare challenges: Help for the most vulnerable communities

How we do business

STEM curriculum in school inspires students to become scientists

Innovation

Future medicine: How will we fight disease in 10 years?

Innovation

Developing biosensors and bioelectronics

Our Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.

Our people

Why don't more females choose careers in science?

Speaking in the GSK Open Series conversations, Nikki Yates, head of UK pharmaceuticals at GSK, and Vivienne Parry, TV science presenter and author, identify a number of factors for the shortfall.

Our people

Should there be positive gender discrimination in science?

Our people

How we are bringing science to life | GSK R&D

How we do business

GSK’s Patrick Vallance on a new generation antibiotics

Innovation

Biolectronic medicines: Harnessing body's electrical language

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Access to healthcare

Our humanitarian work: Saving one million children's lives

Patients & consumers

19 years of support: GSK Impact Awards

See how we are committed to helping charities through the GSK IMPACT Awards.

Our people

Rare Disease Day 2016: What it means to us

Rare Disease Day on 29th February holds personal significance for two colleagues working in our Rare Disease Unit; Jessica Imrie and Julie Venners Christensen both have children with rare disorders.

Innovation

Rare diseases are not that rare

Innovation

Rare diseases: unscrambling the code

How we do business

How we are bringing science to life | GSK R&D

Patrick Vallance is something of a rare breed: a game-keeper turned poacher; an academic who's moved over into industry. And not just any industry, but the pharmaceutical industry.

Innovation

Inspiring the next generation of scientists

Access to healthcare

Tackling malaria in the worst affected countries

Patients & consumers

Alzheimer’s Support: 2015 GSK Impact Award winner

Alzheimer’s Support is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with The King’s Fund.

Patients & consumers

Mental health charity Restore - GSK Impact Awards winner

Patients & consumers

Helping communities | 2015 GSK Impact Award winner

Patients & consumers

Neuromuscular Centre: 2015 GSK Impact Award winner

Neuromuscular Centre in Cheshire supports people affected by Muscular Dystrophy to maintain the best quality of life and is one of ten charities to win a 2015 GSK IMPACT Award, run in partnership with the King’s Fund.

Access to healthcare

Developing vaccine against the malaria virus

How we do business

Humanitarian challenges: Child & maternal mortality stats

Find out how we are doing more than just giving money.

Patients & consumers

The Global Pain Index: an insight into the world of pain

The impact of body pain on sufferers and the people around them is the focus of a new in-depth study carried out by GSK Consumer Healthcare - the GSK Global Pain Index

Our people

On the job with GSK's medical device research team

Access to healthcare

Science hasn't answered all questions on curing HIV

Innovation

Igniting a revolution in scientific research and development

Innovative partnerships between science, business and charities could help tackle some of the most challenging healthcare issues, transforming the prospects of developing countries.

Our people

Volunteering in Kenya: a once in a lifetime experience

PULSE volunteer, Mizanul Islam shares his experience of working with Save the Children in Bungoma County, Kenya for six months in 2015.

Our people

Treating malaria: Making a change from the inside

Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.

How we do business

Improving maternal health & reducing infant mortality in Kenya | GSK

Find out how we are helping to cut maternal and newborn mortality rates in Kenya.

How we do business

See how GSK supports STEM in the real world

Access to healthcare

Benefits of receiving a 'charitable Oscar' | Community charity

How we do business

Disclosing information on payments to doctors has already had positive effects in Europe

Find out how we will be publicly disclosing information on payments and transfers of value that we make to doctors and other healthcare professionals (HCPs).

Access to healthcare

Guardian article: Finding new ways to give mothers and new-borns a healthier start

Scientist Lori Gavrin has first-hand experience of why we need to find new ways to help protect mothers and their newborn babies

Access to healthcare

Malaria: Key facts

Access to healthcare

Statistics and information about malaria

See how malaria still leaves a devastating toll on communities and economies.

How we do business

Turning waste into a resource

Our people

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Access to healthcare

Comic Relief and GSK form a partnership to fight malaria

GSK has teamed up with Comic Relief to improve the lives of millions of people in Africa and Asia. Engineer and GSK executive Andy Wright explains.

How we do business

Bloomberg TV: Sir Andrew Witty, CEO, GSK, discusses antibiotic resistance in Davos

Andrew Witty, Chief Executive Officer, GSK, discusses antibiotic effectiveness, the issues surrounding drug pricing and corporate inversions. He speaks to Bloomberg's Jonathan Ferro and Hans Nichols on "Countdown" from the World Economic Forum in Davos, Switzerland, January 2016.

How we do business

Save the Children partnership: Key facts & stats

Our people

Intrapreneurship: keeping our fingers on the PULSE

We're encouraging our employees to explore new ideas beyond the remit of their role

Innovation

Turbocharging the effect of vaccines

Patients & consumers

Helping to protect yourself against flu

Innovation

Experimental medicine

Studies often employ state-of-the art technology to help scientists and doctors track the effect of a potential new medicine in patients’ bodies.

Innovation

Outgrowing asthma

We have embarked on a pioneering new asthma remission study at the Centre for Therapeutic Target Validation.

Access to healthcare

TEDMED 2015: An interview with curator, Christine McNab

We interview Christine McNab, curator of The Art of Saving a Life.

Patients & consumers

STEM in the real world

At Waldegrave School for Girls in Twickenham there is a drive to enthuse pupils about the possibilities and opportunities that STEM subjects can offer.

Access to healthcare

TEDMED 2015: Art, inspired by vaccination

Patients & consumers

Living every day with COPD: José’s story

Our people

War and peace: Ivo, Nobel prize winner

In the world of business—and scientific research—war metaphors abound. “Hitting our targets.” “Fighting cancer.” What we don’t see are many comparisons to peacekeeping.

Our people

Changing Lives

The PULSE Volunteer programme is GSK’s flagship skills-based volunteering initiative. Launched in 2009, PULSE serves as a matchmaker for GSK and the non-profit sector – connecting the skills of our high-performing employees with the pressing needs of our non-profit partners.

Our people

Formal STEM education not necessary for career in science

GSK apprenticeships offer students keen on a career in science an alternative to the traditional university pathway.

Access to healthcare

Reducing child & maternal death rates in Kenya

Angela Muriuki finds that combating the high death rates in mothers and newborns in parts of Kenya involves knowledge of the culture of the people involved and the practical problems they face accessing healthcare.

Our people

Rare diseases: Q&A with Martin Andrews

How we do business

Less is more with advanced technologies in manufacturing

How we do business

Using biology to increase quality and reduce carbon footprint

We've introduced new manufacturing technologies that will help deliver greater numbers of higher quality medicines more effectively to patients.

Access to healthcare

Five years. 40,000 health workers. 11 million people.

What happened when GSK committed to reinvest 20% of its profits from the least developed countries back into those nations’ healthcare systems?

Access to healthcare

The fight against malaria

By the time the second hand on your wristwatch has circled its dial, a child in Africa will have died of malaria.

Innovation

The science behind sport

The state-of-the-art facility where scientists are using cutting-edge technology to examine body and brain function.

Innovation

Targeting the immune system through open innovation

Access to healthcare

Causes & prevention of malaria: fighting it on the frontline

Access to healthcare

Malaria in Africa: No 'silver bullet' to tackle it

The combination of increased funding, resources and education to fight malaria have contributed to a reduction in deaths from this mosquito-borne disease.

Access to healthcare

On the frontline of Ebola prevention

Read how Robbie worked on the ground to fight Ebola.

Access to healthcare

Ebola: our fast track response

GSK responded to the crisis by contributing humanitarian support and accelerating the development of an investigational Ebola vaccine.

Innovation

Keeping ahead of the game

To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.

Innovation

Fluorescent bacteria - nowhere to hide

Access to healthcare

Making our vaccines more accessible

Our people

How we innovate to save children in Africa | GSK charity

Lisa Bonadonna, head of the partnership at GSK, talks about a product innovation under development.

Access to healthcare

Vaccines - coming in from the cold

‘Thermostability’ - it may sound very technical and complicated, but really it’s all about fridges.

Patients & consumers

Every breath you take: Alison’s story

Imagine if every breath you took was a struggle; imagine waking up in the night short of breath and wheezing.

Access to healthcare

Motivating a global coalition

GSK’s Jon Pender explains why working in partnership was key to addressing the pace of the Ebola outbreak in 2014.

Innovation

Cell and gene therapy: a new era of medicine

Access to healthcare

Fighting Ebola highlights the need for more health workers

Innovation

Enriching our clinical trials data

Finding new ways to use biosensors and mobile health platforms to improve patient care.

How we do business

Why our transaction with Novartis is different

What makes GSK’s recently completed transaction with Novartis different?

Access to healthcare

Ebola vaccine R&D

Learn how we are advancing the development of our GSK/NIH Ebola vaccine candidate.

Access to healthcare

Forming public partnerships

The Ebola crisis has been an unusual and rapidly changing situation. Find out how we are responding.

Access to healthcare

Our humanitarian response response to the Ebola outbreak

Access to healthcare

Malaria: life cycle of a parasite

Our people

A healthier future for Africa

Our VP of east Africa and government affairs, Allan Pamba, explains his desire to improve the health of people in Africa.

Our people

Females in science: The story of a GSK apprentice

Anna Shaw is a Laboratory Analyst apprentice within our manufacturing organisation, based at our Ulverston site.

Our people

Employee volunteering gets personal

Peter Albert couldn’t have known how instrumental his expertise would be in helping fight the Ebola outbreak.

Access to healthcare

The critical workers boosting children’s health

As a community health worker in Liberia – communities rely on people like Christopher for essential healthcare.

How we do business

Changing the way we work with healthcare professionals

Innovation

Understanding human performance

How we do business

Flonase: the journey from prescription to OTC

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

Access to healthcare

Africa’s fight against malaria: how mothers are helping on the ground

In a critical year in the fight against malaria, it will be community health workers and mothers themselves who play a vital role in helping to defeat the disease in Africa

How we do business

How we evaluate our investment options

Redefining the shape of GSK and realising significant value for our shareholders.

How we do business

Increasing access in India

Reaching hard-to-reach villages which currently represent 70% of India’s 1.2 billion population.

Our people

From academia to industry

Our people

From student digs to Buckingham Palace

Access to healthcare

Helping women to give birth safely

Helping midwives like Mary develop their skills and ensure more women give birth safely in Africa.

How we do business

Inhaler recycling

When we analysed our carbon footprint in 2010, two things became clear: we needed to take action to reduce it.

Patients & consumers

Science of a different stripe

How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?

Innovation

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

How we do business

'Rightsizing' our tablet packaging to reduce carbon emissions

Innovation

Can mosquitoes prevent malaria?

Patients & consumers

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

Innovation

Data transparency

We have a long-standing commitment to data transparency.

Patients & consumers

Novamin - the accidental curist

One of the more compelling aspects of scientific research is the unexpected avenues down which it can lead.

Innovation

Inside the Open Lab

Learn how the Tres Cantos Open Lab offers top international scientists and academics the opportunity to pursue their own projects as part of an integrated team.

Our people

Meet Alicia - a graduate engineer

Innovation

Neuroscience: on the brain

Access to healthcare

The 'baby bubble'

The first 48 hours of life can be critical for a newborn baby. Infections like pneumonia, contracted during a baby’s first two days, can prove fatal.

How we do business

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Access to healthcare

Algueta's smile: fighting lymphatic filariasis

Tijana Duric looks after the supply planning for albendazole in our neglected tropical diseases unit.

Access to healthcare

Life after polio: Fatiha's story

Fatiha describes her experience of polio and why she wanted to work for GSK.

Back to top